Genetic markers of immunoglobulin G and susceptibility to breast cancer

Human Immunology

Volumn 73, Issue 11, 2012, Pages 1155-1158

  Pandey, Janardan P ^a   Kistner Griffin, Emily ^a   Iwasaki, Motoki ^b   Bu, Shizhong ^a   Deepe, Ray ^a   Black, Laurel ^a   Kasuga, Yoshio ^c   Hamada, Gerson S ^d   Tsugane, Shoichiro ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NATIONAL CANCER CENTER   (Japan)

^c Nagano Matsushiro General Hospital   (Japan)

^d Nikkei Disease Prevention Center   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ALLOTYPE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1;

ALLELE; ANTIBODY RESPONSE; ARTICLE; BRAZIL; BREAST CANCER; CANCER SUSCEPTIBILITY; CAUCASIAN; CONTROLLED STUDY; GENETIC ANALYSIS; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; IMMUNOGLOBULIN G; POPULATION GROUPS; RECEPTORS, IGG;

EID: 84867844498     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.07.340     Document Type: Article

References (20)

1. Jefferis R., Lefranc M.P. Human immunoglobulin allotypes: possible implications for immunogenicity. MAbs 2009, 1:332-338.
2. Dugoujon J.M., Hazout S., Loirat F., Mourrieras B., Crouau-Roy B., Sanchez-Mazas A. GM haplotype diversity of 82 populations over the world suggests a centrifugal model of human migrations. Am J Phys Anthropol 2004, 125:175-192.
3. Nakao Y., Matsumoto H., Miyazaki T., Watanabe S., Mukojima T., Kawashima R., et al. Immunoglobulin G heavy-chain allotypes as possible genetic markers for human cancer. J Natl Cancer Inst 1981, 67:47-50.
4. Ilić V., Milosević-Jovcić N., Marković D., Petrović S., Stefanović G. A biased Gm haplotype and Gm paraprotein allotype in multiple myeloma suggests a role for the Gm system in myeloma development. Int J Immunogenet 2007, 34:119-125.
5. Pandey J.P., Johnson A.H., Fudenberg H.H., Amos D.B., Gutterman J.U., Hersh E.M. HLA antigens and immunoglobulin allotypes in patients with malignant melanoma. Hum Immunol 1981, 2:185-190.
6. Morell A., Scherz R., Käser H., Skvaril F. Evidence for an association between uncommon Gm phenotypes and neuroblastoma. Lancet 1977, 1:23-24.
7. Pandey J.P., Ebbesen P., Bülow S., Svendsen L.B., Fudenberg H.H. IgG heavy-chain (Gm) allotypes in familial polyposis coli. Am J Hum Genet 1986, 39:133-136.
8. Iwasaki M., Shimada N., Kasuga Y., Yokoyama S., Onuma H., Nishimura H., et al. Fragment c gamma receptor gene polymorphisms and breast cancer risk in case-control studies in Japanese, Japanese Brazilians, and non-Japanese Brazilians. Breast Cancer Res Treat 2011, 126:497-505.
9. Brusco A., de Lange G.G., Boccazzi C., Carbonara A.O. Molecular characterization of G2m(n+) and G2m(n-) allotypes. Immunogenetics 1995, 42:414-417.
10. Balbín M., Grubb A., de Lange G.G., Grubb R. DNA sequences specific for Caucasian G3m(b) and (g) allotypes: allotyping at the genomic level. Immunogenetics 1994, 39:187-193.
11. Pandey J.P., Namboodiri A.M., Kurtenkov O., Nietert P.J. Genetic regulation of antibody responses to human epidermal growth factor receptor 2 (HER-2) in breast cancer. Hum Immunol 2010, 71:1124-1127.
12. Cox B., Richardson A., Graham P., Gislefoss R.E., Jellum E., Rollag H. Breast cancer, cytomegalovirus and Epstein-Barr virus: a nested case-control study. Br J Cancer 2010, 102:1665-1669.
13. Harkins L.E., Matlaf L.A., Soroceanu L., Klemm K., Britt W.J., Wang W., et al. Detection of human cytomegalovirus in normal and neoplastic breast epithelium. Herpesviridae 2010, 1:8.
14. Namboodiri A.M., Pandey J.P. The human cytomegalovirus TRL11/IRL11-encoded FcγR binds differentially to allelic variants of immunoglobulin G1. Arch Virol 2011, 156:907-910.
15. Atalay R., Zimmermann A., Wagner M., Borst E., Benz C., Messerle M., et al. Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs. J Virol 2002, 76:8596-8608.
16. Pandey J.P., Immunoglobulin G.M. Genes and IgG antibodies to cytomegalovirus in patients with systemic sclerosis. Clin Exp Rheumatol 2004, 22:S35-S37.
17. O'Connell P., Fischbach K., Hilsenbeck S., Mohsin S.K., Fuqua S.A., Clark G.M., et al. Loss of heterozygosity at D14S62 and metastatic potential of breast cancer. J Natl Cancer Inst 1999, 91:1391-1397.
18. Figueroa J.D., Garcia-Closas M., Humphreys M., Platte R., Hopper J.L., Southey M.C., Van't Veer L.J., et al. Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. Hum Mol Genet 2011, 20:4693-4706.
19. Pandey J.P. Genomewide association studies and assessment of the risk of disease. N Engl J Med 2010, 363:2076-2077.
20. Namboodiri A.M., Pandey J.P. Differential inhibition of trastuzumab and cetuximab induced cytotoxicity of cancer cells by IgG1 expressing different GM allotypes. Clin Exp Immunol 2011, 166:361-365.